Overview

COMMITTED TO THE DESIGN, DEVELOPMENT, AND DELIVERY OF INNOVATIVE AND CREATIVE EVIDENCE-BASED EDUCATION PROGRAMS


A Patient With Severe Asthma in Need of Additional Control

Severe asthma is thought to affect about 5% to 10% of the total population of patients with asthma. The detrimental consequences of uncontrolled severe asthma are significant, leading to serious exacerbations, deterioration of lung function, and pronounced impact on quality of life. The emergence of biologic therapies has revolutionized the treatment of severe asthma. Dr. Flavia Hoyte consults ...
Integritas Communications

Answering The Call in Nonadvanced Systemic Mastocytosis

Target Audience The design of this activity addresses the needs of clinical immunologists/allergists, dermatologists, gastroenterologists, hematologists, and other specialist clinicians who diagnose or manage nonadvanced systemic mastocytosis (SM). Program Overview Nonadvanced SM is a challenging disorder to diagnose and manage due to the heterogeneity of symptoms, anaphylactic triggers, an...
Integritas Communications

Answering the Call in Severe Asthma Expanding Roles for Biologic Treatment Regimens

This enduring Call-a-Colleague™ educational program will guide attendees through the long-term management of severe asthma. Expert faculty will provide actionable recommendations on evaluation strategies that consider underlying mechanism of disease, data on newer biologic treatment options, and most importantly, the use of these therapies in current day practice. Interspersed throughout the p...
Integritas Communications

Assessment of Asthma Control

Although asthma treatments are widely available, between one-third and one-half of patients continue to have symptoms that regularly interfere with everyday life. These asthma-related symptoms and exacerbations result in almost 2 million emergency department visits each year, which often lead to inpatient hospital stays. Thus, there is a clear need for ongoing education about asthma management, ...
Integritas Communications

AxSpA Boot Camp: Are You Up to Date on Recent Advances?

With a multitude of possible clinical presentations and a lack of validated diagnostic criteria, late or missed diagnosis of AxSpA is all too common in clinical practice. Further complicating diagnosis, a subset of patients with AxSpA do not exhibit radiographic changes on plain film x-ray. With recent advances in the therapeutic armamentarium able to halt the irreversible structural changes ass...
Integritas Communications

Can You Compete in Early Cancer Detection

This activity is an informative and engaging presentation about blood-based multi-cancer early detection MCED screening in the primary care setting. Drs. Massart, Vega, and Whittington will provide key data related to current gaps in cancer surveillance, the science and data behind MCEDs, and information on how to implement MCED screening into practice.
Integritas Communications

Cardiovascular Considerations in COPD Management

With cardiovascular disease coexisting in up to 60% of COPD cases, optimal management of each disease is imperative to successful patient outcomes. In this Phone-a-Friend episode, Dr. MeiLan Han consults with Dr. Ty Gluckman to discuss a patient with a 5-year history of COPD and cardiovascular risk factors that may be contributing to his persistent symptoms.
Integritas Communications

Clearing a Path in Chronic Rhinosinusitis With Nasal Polyps: Closing Gaps in Diagnosis and Treatment

As many as half of patients with CRSwNP suffer from uncontrolled symptoms on a daily basis, all of which have a negative impact on both physical and mental health. Effective biological and surgical therapies for CRSwNP are becoming increasingly available and best practices for their use as well as placement within management algorithms are constantly evolving. Clearing a Path in Chronic Rhinosin...
Integritas Communications

Clinical Consults in Severe Asthma: New Approaches to Targeted Therapy

As management options for the treatment of severe asthma continue to expand with the addition of effective biologic therapies, physicians often consult colleagues for advice on complex cases or challenging issues. This 3-episode Phone-a-Friend series features 3 expert physicians asking and answering questions related to the management of severe asthma. The series will cover a variety of topics, ...
Integritas Communications

Diagnosis and Management of Patients With Predominant Skin Symptoms

The educational design of this activity addresses the needs of allergy/clinical immunology, gastroenterology, dermatology, and hematology clinicians who manage patients with nonadvanced systemic mastocytosis. Nonadvanced systemic mastocytosis (SM) is a group of rare disorders characterized by mast cell accumulation that results in a significant and varied symptomatic burden to the patient. T...
Integritas Communications

Endometriosis Boot Camp: Exploring Patient Perspectives to Improve Diagnosis and Management

Endometriosis is one of the most common benign gynecologic conditions that occur during a woman’s reproductive years. Despite the high prevalence of this disease, a large proportion of women with endometriosis remain undiagnosed and untreated. Unfortunately, even after diagnosis and treatment, recurrent and persistent pain are common and represent a significant challenge for patients and healt...
Integritas Communications

Highlights of the 2023 EULAR Guideline Updates in SLE- What you need to know!

This educational program will review the latest updates to the European Alliance of Associations for Rheumatology (EULAR) guidelines for the treatment of SLE and lupus nephritis (LN). Dr. Eric Morand highlights the most important changes to the guidelines and gives key insights into actionable changes that impact individualized patient care.
Integritas Communications

Hitting The Bullseye in NSCLC

Lung cancer is the second most common cancer in both men and women and is the leading cause of cancer-related deaths. The majority of lung cancer cases are categorized as NSCLC, which has a low overall 5-year survival rate, especially when it is diagnosed at advanced, unresectable stages. Recent advances in the treatment landscape have yielded promising improvements in progression-free survival ...
Integritas Communications

Hot Topics in Blood-based Cancer Screening: Key Information on Multi-Cancer Early Detection from 2023 Spring Oncology Meetings

Early detection of cancer is essential to reducing the significant burdens associated with it. When cancer is detected at earlier stages, treatments can be initiated sooner, resulting in improved outcomes, reduced morbidity and mortality, and better quality of life. While the implementation of current screening guidelines has resulted in an overall reduction in cancer deaths, only 25% of cancers...
Integritas Communications

Improving Alzheimer’s Disease Management: Updates on Patient Diagnosis and Treatment

The face of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) diagnosis and management is rapidly changing. A growing understanding of AD pathophysiology has shaped research of targeted therapies and helped clinicians better understand the causes of the disease and the utility of biomarkers. Though cognitive testing is still a critical component of diagnosis, it no longer stands alo...
Integritas Communications

LET'S TALK: Tackling Complex Issues Regarding SM-AHN Management A Monday Morning Joe Online Educational Activity

Systemic mastocytosis (SM) is a group of rare disorders characterized by the accumulation of mast cells in internal tissues and organs. The pathogenesis of SM is linked to a characteristic exon 17 D816V mutation of the KIT gene. Systemic mastocytosis with associated hematologic neoplasms (SM-AHN) is an advanced subtype of SM that is associated with a shortened median survival time. Recent advanc...
Integritas Communications

Making the Call in Nonadvanced Systemic Mastocytosis Optimizing Multidisciplinary Management

Series Overview Nonadvanced systemic mastocytosis (SM) is a group of rare disorders characterized by mast cell accumulation that results in a significant and varied symptomatic burden to the patient. The most prevalent of these symptoms include gastrointestinal symptoms, dermatological symptoms, and recurrent anaphylaxis in response to a variety of triggers such as food, insect venom, and medic...
Integritas Communications

Managing the Patient With Severe Asthma and Common Comorbidities

Comorbid disease is common amongst patients with asthma and may lead to worsening asthma symptoms if not properly identified and managed. Furthermore, some patients may not respond to their first biologic treatment option, confounding management and selection of next line therapy. Dr. Njira Lugogo consults with Dr. Flavia Hoyte to discuss a treatment plan for her patient with severe, allergic as...
Integritas Communications

PrEP’ing in the 2020s: Empowering PCPs to Prevent HIV

This activity is designed to empower and educate participants to offer preexposure prophylaxis (PrEP) for HIV prevention in the primary care setting. Participants will learn how to identify patients at high risk for acquiring HIV, and how to have non-biased conversations about sexual health. Through a patient-centered lens, the activity will cover implementation of PrEP services, including how t...
Integritas Communications

Putting Together Clues in HIV, CVD, T2D, and CKD

As people with HIV live longer, they can develop common comorbidities affecting aging patients, such as type 2 diabetes (T2D), cardiovascular disease (CVD), and chronic kidney disease (CKD). Further, weight gain may be seen in some patients, though the role of antiretroviral therapy (ART) is still under investigation. Clinicians should become familiar with treatment guidelines, drug-drug interac...
Integritas Communications

Raising the Bar in ATTR Amyloidosis A Training Set on Diagnosis and Treatment

There is considerable heterogeneity in the clinical manifestations of ATTR amyloidosis, which are often dependent on both genetic and environmental factors. Once a fatal diagnosis with no effective therapies available, research in ATTR amyloidosis is rapidly evolving and new pharmacotherapies that demonstrate improved quality of life and life expectancy for patients have been developed. Despite ...
Integritas Communications

Reducing Risks in Asthma: Mucus Plugs and Airway Obstruction

Target Audience The educational design of this activity addresses the needs of pulmonology and clinical immunology clinicians who manage patients with severe asthma who are at risk for mucus plugs. Program Overview This Point-of-Care 201 program has been designed to educate and promote critical thinking through a discussion-based format that is accompanied by 3-dimensional animation. Expert...
Integritas Communications

Rescue Therapies for Asthma

Although asthma treatments are widely available, between one-third and one-half of patients continue to have symptoms that regularly interfere with everyday life. These asthma-related symptoms and exacerbations result in almost 2 million emergency department visits each year, which often lead to inpatient hospital stays. Thus, there is a clear need for ongoing education about asthma management, ...
Integritas Communications

The PrEP Journey Charting the Course Through HIV Prevention

HIV prevention with preexposure prophylaxis (PrEP) is an essential tool for clinicians to help end the HIV epidemic. In this case-based interactive activity, you will learn the basics of assessing HIV risk, conversing with patients about sexual health, and providing PrEP, from initiation to monitoring and follow-up. Then, more challenging cases will illustrate the nuances of providing PrEP based...
Integritas Communications

Top 10 COVID-19 Special Population Queries

Even though the COVID-19 pandemic is slowly becoming endemic, there are still certain populations at higher risk of progressing to severe COVID-19 should they become infected with SARS-CoV-2. These include immunocompromised groups, older patients, patients with HIV, disabilities, challenges in social determinants of health, and racial or ethnic minorities. There are treatment considerations for ...
Integritas Communications

TOP 10 Early Cancer Detection Queries What You Need to Know About Blood-Based Screening in Primary Care

In this “Top 10 Early Cancer Detection Queries” program, Dr. Mylynda Massart answers the 10 questions most commonly asked by primary care clinicians about blood-based multi-cancer early detection (MCED) tests. Some of the topics addressed are the science behind MCEDs, their accuracy, how MCEDs compare to other screening modalities, and integration of MCED testing into primary care practice.
Integritas Communications

Top 10 Questions on Biomarkers in Early Alzheimer’s Disease: Improving Diagnosis and Use of Targeted Therapies

The past several years have seen numerous advances in Alzheimer’s disease (AD) diagnosis and management. Most recently, approval of antiamyloid monoclonal antibodies has revolutionized AD management and has required that patients have amyloid burden verified prior to initiating treatment. Biomarkers, whether obtained from cerebrospinal fluid (CSF) or positron emission tomography (PET) scans, a...
Integritas Communications

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map